Basic Information | |
---|---|
Species | Glycine max |
Cazyme ID | Glyma17g32140.2 |
Family | GT47 |
Protein Properties | Length: 483 Molecular Weight: 55216.7 Isoelectric Point: 9.4819 |
Chromosome | Chromosome/Scaffold: 17 Start: 35453661 End: 35461111 |
Description | Exostosin family protein |
View CDS |
External Links |
---|
NCBI Taxonomy |
Plaza |
CAZyDB |
Signature Domain Download full data set without filtering | |||
---|---|---|---|
Family | Start | End | Evalue |
GT47 | 149 | 434 | 0 |
KIFKVYVYPDGDLPIAHDGPCKDIYSIEGRFLHEMEHGAGRFRTNDPNAAHVFFLPFSVTWMVKYLYTPLSFNVTPLKKFVSDYVRVVSTRHPFWNITHG ADHFMLACHDWGPHASQGNPFLYNTSIRVLCNANTSEGFNPRKDVSLPEIHLYGGEVSPKLLSPPPDTAPRRYLAFFSGGLHGPIRPALLGHWKNHDEND VIRVYEYLPKDLDYYSFMLTSKFCLCPSGHEVASPRIVEAIYAECVPVILSEYYVLPFSDVLQWEAFSVQVDVSDIPRLKEILSAI |
Full Sequence |
---|
Protein Sequence Length: 483 Download |
MEIPRKYLLS PILSLILLSF IIVVVLRPCQ LLEFAPIIAG SKPAYSVPLD SLRTKLSSEN 60 QLHAVGNSGE LRRNKFRNRT ATRKVGKLEQ RLAAARAAMR KVASESEGER SNLSVATTAR 120 DDSYHRYVPA GAIYRNARLF YRSYLEMEKI FKVYVYPDGD LPIAHDGPCK DIYSIEGRFL 180 HEMEHGAGRF RTNDPNAAHV FFLPFSVTWM VKYLYTPLSF NVTPLKKFVS DYVRVVSTRH 240 PFWNITHGAD HFMLACHDWG PHASQGNPFL YNTSIRVLCN ANTSEGFNPR KDVSLPEIHL 300 YGGEVSPKLL SPPPDTAPRR YLAFFSGGLH GPIRPALLGH WKNHDENDVI RVYEYLPKDL 360 DYYSFMLTSK FCLCPSGHEV ASPRIVEAIY AECVPVILSE YYVLPFSDVL QWEAFSVQVD 420 VSDIPRLKEI LSAISEDKYR KLKEGVKAVR RHFTLNRPAK RFDVFHMILH SIWLRRLNIE 480 LR* |
Functional Domains Download unfiltered results here | ||||||||
---|---|---|---|---|---|---|---|---|
Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
pfam03016 | Exostosin | 8.0e-67 | 147 | 434 | 305 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. |
Gene Ontology | |
---|---|
GO Term | Description |
GO:0016020 | membrane |
Annotations - NR Download unfiltered results here | |||||||
---|---|---|---|---|---|---|---|
Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
EMBL | CBI21064.1 | 0 | 39 | 481 | 37 | 477 | unnamed protein product [Vitis vinifera] |
RefSeq | NP_197913.4 | 0 | 88 | 481 | 101 | 479 | catalytic [Arabidopsis thaliana] |
RefSeq | XP_002285237.1 | 0 | 147 | 481 | 1 | 333 | PREDICTED: hypothetical protein [Vitis vinifera] |
RefSeq | XP_002324871.1 | 0 | 147 | 481 | 1 | 333 | predicted protein [Populus trichocarpa] |
RefSeq | XP_002515489.1 | 0 | 13 | 481 | 17 | 480 | catalytic, putative [Ricinus communis] |
Metabolic Pathways | |||
---|---|---|---|
Pathway Name | Reaction | EC | Protein Name |
xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |